Nepicastat

Generic Name: Nepicastat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₄H_₁₅F_₂N_₃S

CAS Number: 173997-05-2

Unique Ingredient Identifier: VPG12K4540

Background: Nepicastat has been investigated for the treatment of Cocaine Dependence and Posttraumatic Stress Disorder.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Multi-Center Trial of Nepicastat for Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Nepicastat
Drug: Placebo

First Posted Date: 2012-10-11

Last Posted Date: 2017-05-18

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 179

Registration Number: NCT01704196

Locations: 🇺🇸
VA Medical Center - Denver, CO, Denver, Colorado, United States
🇺🇸
Cincinnati Addiction Research Center, Cincinnati, Ohio, United States
🇺🇸
Mountain Manor Treatment Center at Baltimore, Baltimore, Maryland, United States

and more 7 locations

Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans

Phase 2

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Placebo
Drug: Nepicastat

First Posted Date: 2008-04-16

Last Posted Date: 2017-10-13

Lead Sponsor: Tuscaloosa Research & Education Advancement Corporation

Target Recruit Count: 100

Registration Number: NCT00659230

Locations: 🇺🇸
VA San Diego Healthcare System, San Diego, California, United States
🇺🇸
James J.Peters VA Medical Center, The Bronx, New York, United States
🇺🇸
Tuscaloosa VAMC, Tuscaloosa, Alabama, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy